Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix ® in Healthy Adult Volunteers
Conditions: Shingles; Herpes Zoster; Vaccine-Preventable Diseases Interventions: Biological: Z-1018; Biological: Shingrix Sponsor: Dynavax Technologies Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Herpes | Research | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine